99 related articles for article (PubMed ID: 23426449)
1. Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer.
Lee TY; Lin JT; Wu CC; Yu CC; Wu MS; Lee TC; Chen HP; Wu CY
J Clin Gastroenterol; 2013 Jul; 47(6):e55-9. PubMed ID: 23426449
[TBL] [Abstract][Full Text] [Related]
2. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
3. SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility.
Ju H; Lim B; Kim M; Noh SM; Kim WH; Ihm C; Choi BY; Kim YS; Kang C
Cancer; 2010 Sep; 116(18):4248-55. PubMed ID: 20549826
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer.
Zhao F; Chen X; Meng T; Hao B; Zhang Z; Zhang G
BMC Cancer; 2012 Oct; 12():477. PubMed ID: 23072570
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population.
Dey S; Stalin S; Gupta A; Saha D; Kesh K; Swarnakar S
Mol Carcinog; 2012 Oct; 51 Suppl 1():E42-53. PubMed ID: 22121090
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.
Dong QZ; Zhang XF; Zhao Y; Jia HL; Zhou HJ; Dai C; Sun HJ; Qin Y; Zhang WD; Ren N; Ye QH; Qin LX
Hepatology; 2013 Mar; 57(3):1024-34. PubMed ID: 23079960
[TBL] [Abstract][Full Text] [Related]
9. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan.
Taguchi A; Ohmiya N; Shirai K; Mabuchi N; Itoh A; Hirooka Y; Niwa Y; Goto H
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2487-93. PubMed ID: 16284368
[TBL] [Abstract][Full Text] [Related]
11. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
[TBL] [Abstract][Full Text] [Related]
12. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
[TBL] [Abstract][Full Text] [Related]
13. Increased genetic susceptibility to intestinal-type gastric cancer is associated with increased activity of the RUNX3 distal promoter.
Lim B; Ju H; Kim M; Kang C
Cancer; 2011 Nov; 117(22):5161-71. PubMed ID: 21523770
[TBL] [Abstract][Full Text] [Related]
14. Role of CD14 promoter polymorphisms in Helicobacter pylori infection--related gastric carcinoma.
Zhao D; Sun T; Zhang X; Guo Y; Yu D; Yang M; Tan W; Wang G; Lin D
Clin Cancer Res; 2007 Apr; 13(8):2362-8. PubMed ID: 17438094
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.
Xu Z; Zhu H; Luk JM; Wu D; Gu D; Gong W; Tan Y; Zhou J; Tang J; Zhang Z; Wang M; Chen J
Cancer; 2012 Nov; 118(22):5489-96. PubMed ID: 22517484
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
18. Maspin genetically and functionally associates with gastric cancer by regulating cell cycle progression.
Kim M; Ju H; Lim B; Kang C
Carcinogenesis; 2012 Dec; 33(12):2344-50. PubMed ID: 22962304
[TBL] [Abstract][Full Text] [Related]
19. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
20. Role of cytokine gene polymorphisms in gastric cancer risk in Chile.
Gonzalez-Hormazabal P; Musleh M; Bustamante M; Stambuk J; Escandar S; Valladares H; Lanzarini E; Chiong H; Rojas J; Castro VG; Rubio-Reyes C; Jara L; Berger Z
Anticancer Res; 2014 Jul; 34(7):3523-30. PubMed ID: 24982364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
